A 28-year-old woman with a history of intravenous drug use presents with a 5-day history of left shoulder pain, swelling, and fever (38.2°C). Synovial fluid obtained by arthrocentesis shows WBC 62,000/μL (90% neutrophils), glucose 22 mg/dL (serum 110 mg/dL), protein 5.8 g/dL, and Gram stain is negative. Blood cultures are pending. She is allergic to penicillin (anaphylaxis). What is the most appropriate immediate antibiotic regimen?

Explanation

## Clinical Context This patient has confirmed septic arthritis (synovial WBC 62,000/μL with 90% neutrophils, low glucose, elevated protein, negative Gram stain) with a history of IVDU and **true penicillin anaphylaxis**. IVDU significantly raises the risk of *Staphylococcus aureus* (including MRSA) and Gram-negative organisms (including *Pseudomonas aeruginosa*). ## Empiric Antibiotic Coverage in Septic Arthritis with Penicillin Anaphylaxis **Key Point:** In septic arthritis, empiric antibiotic selection must account for: 1. **Allergy history** — true anaphylaxis to penicillin mandates avoidance of all β-lactams (including cephalosporins, which carry ~1–3% cross-reactivity risk — unacceptable in anaphylaxis) 2. **Risk factors** — IVDU increases risk of MRSA and Gram-negative organisms (especially *Pseudomonas*) 3. **Gram stain result** — negative Gram stain does not exclude infection; sensitivity is ~60% ## Why Vancomycin + Fluoroquinolone (Levofloxacin) Is Correct | Agent | Coverage | Rationale | |---|---|---| | **Vancomycin IV** | MRSA, MSSA, Gram-positive cocci | Gold standard for MRSA; no β-lactam cross-reactivity | | **Levofloxacin IV** | Gram-negative organisms including *Pseudomonas*, atypicals | Safe in penicillin anaphylaxis; no β-lactam structure | **High-Yield:** In a patient with **true penicillin anaphylaxis** and IVDU, the standard empiric regimen is **Vancomycin + a fluoroquinolone (levofloxacin or ciprofloxacin)**. This combination: - Covers MRSA (vancomycin) - Covers Gram-negative organisms including *Pseudomonas* (fluoroquinolone) - Avoids all β-lactams (no cephalosporins, no carbapenems) **Clinical Pearl (per Harrison's Principles of Internal Medicine):** IVDU-associated septic arthritis is most commonly caused by *S. aureus* (including MRSA), but Gram-negative coverage (especially *Pseudomonas*) is essential in this population. Fluoroquinolones provide excellent Gram-negative coverage and are safe in penicillin anaphylaxis. ## Why the Other Options Are Incorrect - **Option A (Vancomycin + Clindamycin):** Clindamycin does NOT provide adequate Gram-negative coverage, which is critical in IVDU patients. This combination leaves *Pseudomonas* and other Gram-negatives uncovered. - **Option C (Vancomycin + Ceftriaxone):** Ceftriaxone is a cephalosporin (β-lactam). In **true penicillin anaphylaxis**, cephalosporins are contraindicated due to cross-reactivity risk (~1–3%). This is unacceptable in an acute emergency setting. - **Option D (Clindamycin monotherapy):** Monotherapy is inadequate for septic arthritis in an IVDU patient; clindamycin lacks Gram-negative coverage and does not cover MRSA reliably. ## Dosing Reminder - **Vancomycin:** 15–20 mg/kg IV Q8–12H (target AUC/MIC 400–600 or trough 15–20 μg/mL) - **Levofloxacin:** 500–750 mg IV Q24H - Adjust vancomycin for renal function; monitor drug levels **Reference:** Harrison's Principles of Internal Medicine, 21st ed.; Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases.